Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2016, Article ID 2861915, 9 pages
http://dx.doi.org/10.1155/2016/2861915
Research Article

Preparation and Characterization of Baicalein-Loaded Nanoliposomes for Antitumor Therapy

1Department of Biological Engineering, College of Environment & Chemical Engineering, Yanshan University, No. 438 Hebei Street, Qinhuangdao 066004, China
2The First Hospital of Qinhuangdao, No. 258, Wenhua Road, Haigang District, Qinhuangdao, Hebei 066000, China
3The Hospital of Yanshan University, No. 438 Hebei Street, Qinhuangdao 066004, China
4School of Finance, Nankai University, No. 38 Tongshuo Road, Tianjin 300350, China

Received 1 April 2016; Revised 21 May 2016; Accepted 7 June 2016

Academic Editor: Mingqiang Li

Copyright © 2016 Kun Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. D. Bangham, M. M. Standish, and J. C. Watkins, “Diffusion of univalent ions across the lamellae of swollen phospholipids,” Journal of Molecular Biology, vol. 13, no. 1, pp. 238–252, 1965. View at Publisher · View at Google Scholar · View at Scopus
  2. J. H. Kim and M. W. Kim, “In-situ observation of the inside-to-outside molecular transport of a liposome,” The Journal of Physical Chemistry B, vol. 112, no. 49, pp. 15673–15677, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. Z. Fang and B. Bhandari, “Encapsulation of polyphenols—a review,” Trends in Food Science and Technology, vol. 21, no. 10, pp. 510–523, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. P. Patil and S. Jadhav, “Novel methods for liposome preparation,” Chemistry and Physics of Lipids, vol. 177, pp. 8–18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. P. G. Schmidt, J. P. Adler-Moore, E. A. Forssen et al., “Unilamellar liposomes for anticancer and antifungal therapy,” in Medical Applications of Liposomes, pp. 703–731, Elsevier, New York, NY, USA, 1998. View at Google Scholar
  6. R. Solomon and A. A. Gabizon, “Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal doxorubicin,” Clinical Lymphoma and Myeloma, vol. 8, no. 1, pp. 21–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. Y.-M. Ning, K. He, R. Dagher et al., “Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myeloma,” Oncology, vol. 21, no. 12, pp. 1503–1516, 2007. View at Google Scholar · View at Scopus
  8. L. Bracci, G. Schiavoni, A. Sistigu, and F. Belardelli, “Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer,” Cell Death and Differentiation, vol. 21, no. 1, pp. 15–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Gabizon, H. Shmeeda, and Y. Barenholz, “Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies,” Clinical Pharmacokinetics, vol. 42, no. 5, pp. 419–436, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Fang, H. Nakamura, and H. Maeda, “The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect,” Advanced Drug Delivery Reviews, vol. 63, no. 3, pp. 136–151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Maeda, “Macromolecular therapeutics in cancer treatment: the EPR effect and beyond,” Journal of Controlled Release, vol. 164, no. 2, pp. 138–144, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. V. P. Torchilin, “Recent advances with liposomes as pharmaceutical carriers,” Nature Reviews Drug Discovery, vol. 4, no. 2, pp. 145–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Li and Y. Chen, “Advances in flavonoids mechanism of action of lung cancer,” Rational Drug Use, vol. 4, pp. 172–174, 2014. View at Google Scholar
  14. J. Liang, W. Wu, Q. Liu, and S. Chen, “Long-circulating nanoliposomes (LCNs) sustained delivery of baicalein (BAI) with desired oral bioavailability in vivo,” Drug Delivery, vol. 20, no. 8, pp. 319–323, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Ikemoto, K. Sugimura, N. Yoshida et al., “Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines,” Urology, vol. 55, no. 6, pp. 951–955, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. F. M. Menger, J. S. Keiper, and S. J. Lee, “Adhesion of giant liposomes as observed by light microscopy,” Langmuir, vol. 13, no. 17, pp. 4614–4620, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Sun, N. Zhang, A. Li, W. Zou, and W. Xu, “Preparation and evaluation of N3-O-toluyl-fluorouracil-loaded liposomes,” International Journal of Pharmaceutics, vol. 353, no. 1-2, pp. 243–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Wei, Z. Xue, Y. Ye, Y. Huang, and L. Zhao, “Paclitaxel targeting to lungs by way of liposomes prepared by the effervescent dispersion technique,” Archives of Pharmacal Research, vol. 37, no. 6, pp. 728–737, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Vichai and K. Kirtikara, “Sulforhodamine B colorimetric assay for cytotoxicity screening,” Nature Protocols, vol. 1, no. 3, pp. 1112–1116, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Xu, B. Zhao, and D. He, “Synthesis of highly dispersed nanoscaled CoQ10 liposome by supercritical fluid,” Materials Letters, vol. 142, pp. 283–286, 2015. View at Publisher · View at Google Scholar · View at Scopus